IP-driven solutions for enhanced clinical efficiency
Our platform technologies combine scientific innovation with strategic intellectual property development to create differentiated pharmaceutical products with enhanced clinical performance, regulatory strength, and long-term market value.
Intellectual property (IP) protection:
Creating a “patent thicket” around products through unique delivery mechanisms. Design around strategies for Paragraph IV filings.
Clinical efficiency:
Biorelevant media and IVIVC tools for the success of test product in bioequivalence.
Scientific innovation:
Creating innovative compositions and processes for patenting.